{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T05:06:03Z","timestamp":1732424763016,"version":"3.28.0"},"reference-count":40,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2024,11,29]]},"DOI":"10.7883\/yoken.jjid.2024.184","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T22:16:59Z","timestamp":1719526619000},"page":"301-310","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus"],"prefix":"10.7883","volume":"77","author":[{"given":"Alitzel","family":"Anzurez","sequence":"first","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"},{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucky","family":"Runtuwene","sequence":"additional","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Thu Thao","family":"Dang","sequence":"additional","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"},{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Nakayama-Hosoya","sequence":"additional","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Koga","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama Municipal Citizens\u2019 Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama Municipal Citizens\u2019 Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama Municipal Citizens\u2019 Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama Municipal Citizens\u2019 Hospital, Japan"},{"name":"Department of Respiratory Medicine, Yokohama Municipal Citizens\u2019 Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuo","family":"Tachikawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama Municipal Citizens\u2019 Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Matano","sequence":"additional","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"},{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan"},{"name":"Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kawana-Tachikawa","sequence":"additional","affiliation":[{"name":"AIDS Research Center, National Institute of Infectious Diseases, Japan"},{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan"},{"name":"Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506.","DOI":"10.1016\/j.coi.2012.05.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690-e700.","DOI":"10.1016\/S2352-3018(21)00239-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kassanjee R, Davies MA, Ngwenya O, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104.","DOI":"10.1002\/jia2.26104"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wit FWNM, Reiss P, Rijnders B, et al. COVID-19 in people with HIV in the Netherlands. AIDS. 2023;37:1671-1681.","DOI":"10.1097\/QAD.0000000000003597"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Patel VV, Felsen UR, Fisher M, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224-230.","DOI":"10.1097\/QAI.0000000000002578"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Favara G, Barchitta M, Maugeri A, et al. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.","DOI":"10.7189\/jogh.12.05036"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moller IK, Gisslen M, Wagner P, et al. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023;24:1045-1055.","DOI":"10.1111\/hiv.13515"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636-1643.","DOI":"10.1038\/s41591-020-1051-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakayama R, Bunya N, Tagami T, et al. Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study. BMC Infect Dis. 2023;23:814.","DOI":"10.1186\/s12879-023-08817-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol. 2011;89:785-795.","DOI":"10.1189\/jlb.0410231"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Coindre S, Tchitchek N, Alaoui L, et al. Mass cytometry analysis reveals complex cell-state modifications of blood myeloid cells during HIV infection. Front Immunol. 2019;10:2677.","DOI":"10.3389\/fimmu.2019.02677"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee MY, Upadhyay AA, Walum H, et al. Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection. PLoS Pathog. 2021;17:e1009674.","DOI":"10.1371\/journal.ppat.1009674"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hove-Skovsgaard M, Moller DL, Hald A, et al. Improved induced innate immune response after cART initiation in people with HIV. Front Immunol. 2022;13:974767.","DOI":"10.3389\/fimmu.2022.974767"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8<sup>+<\/sup> T cells. Blood. 2003;101:2711-2720.","DOI":"10.1182\/blood-2002-07-2103"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeficiency virus-specific CD8<sup>+<\/sup> T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876-11889.","DOI":"10.1128\/JVI.01153-09"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354.","DOI":"10.1038\/nature05115"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nkosi T, Chasara C, Papadopoulos AO, et al. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition. Elife. 2022;11:e78374.","DOI":"10.7554\/eLife.78374"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hwa SH, Snyman J, Bernstein M, et al. Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant. J Infect Dis. 2023;227:211-220.","DOI":"10.1093\/infdis\/jiac343"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Khan K, Lustig G, Bernstein M, et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin Infect Dis. 2022;75:e857-e864.","DOI":"10.1093\/cid\/ciab1008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Alrubayyi A, Gea-Mallorqui E, Touizer E, et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12:5839.","DOI":"10.1038\/s41467-021-26137-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Donadeu L, Tiraboschi JM, Scevola S, et al. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. AIDS. 2022;36:1373-1382.","DOI":"10.1097\/QAD.0000000000003276"},{"key":"22","unstructured":"22. Wei T, Simko V. R package &apos;corrplot&apos;: visualization of a correlation matrix (Version 0.92). Available at &lt;https:\/\/github.com\/taiyun\/corrplot&gt;, 2021. Accessed July 23, 2024."},{"key":"23","unstructured":"23. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at &lt;https:\/\/www.R-project.org\/&gt;, 2021. Accessed July 23, 2024."},{"key":"24","unstructured":"24. Kassambara A, Mundt f. Factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7, Available at &lt;https:\/\/CRAN.R-project.org\/package=factoextra&gt;, 2020. Accessed July 23, 2024."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sebastien Le JJ, Francois Husson. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18.","DOI":"10.18637\/jss.v025.i01"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75.","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022;13:832394.","DOI":"10.3389\/fimmu.2022.832394"},{"key":"28","unstructured":"28. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7-E26."},{"key":"29","unstructured":"29. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tilton JC, Manion MM, Luskin MR, et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008;82:3997-4006.","DOI":"10.1128\/JVI.01545-07"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mangino G, Percario ZA, Fiorucci G, et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One. 2011;6:e22982.","DOI":"10.1371\/journal.pone.0022982"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853.","DOI":"10.1097\/QAD.0b013e328351f756"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of innate immune responses in macrophages. Viruses. 2020;12:711.","DOI":"10.3390\/v12070711"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666.","DOI":"10.4049\/jimmunol.168.7.3660"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8<sup>+<\/sup> T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101.","DOI":"10.1182\/blood.V96.9.3094.h8003094_3094_3101"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation\/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses. 2012;28:702-714.","DOI":"10.1089\/aid.2011.0073"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75.","DOI":"10.1186\/s12933-023-02097-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Guha D, Misra V, Yin J, et al. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37:2137-2147.","DOI":"10.1101\/2023.07.23.23293053"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Noel N, Boufassa F, L\u00e9curoux C, et al. Elevated IP10 levels are associated with immune activation and low CD4<sup>+<\/sup> T-cell counts in HIV controller patients. AIDS. 2014;28:467-476.","DOI":"10.1097\/QAD.0000000000000174"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Semulimi AW, Batte C, Bayiyana A, et al. Serum E-selectin and endothelial cell-specific molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study. AIDS Res Ther. 2023;20:26.","DOI":"10.1186\/s12981-023-00519-x"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/77\/6\/77_JJID.2024.184\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:16:46Z","timestamp":1732335406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/77\/6\/77_JJID.2024.184\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2024.184","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"type":"print","value":"1344-6304"},{"type":"electronic","value":"1884-2836"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"article-number":"JJID.2024.184"}}